Umckaloabo Drug Interactions, Uses, Effectiveness, Safety & More
What is this page for?
First and foremost: how Umckaloabo interacts with medications. The heart of this page is the interaction list — every drug Umckaloabo is known to interact with, and how serious each one is.
But these pages have grown well beyond that into a full monograph — what Umckaloabo is, what people use it for and how strong the evidence is, its safety and side effects, and answers to the questions we’re asked most — written and reviewed by the clinical staff at HelloPharmacist. It’s educational information from our licensed clinical databases, not medical advice, and we don’t sell or endorse products. Our editorial policy
Check Umckaloabo against your medication
Add one medicationUmckaloabo Drug Interactions: The Bottom Line
From the HelloPharmacist Editorial Team · Updated July 2026Based on the available evidence, the overall risk of a clinically significant Umckaloabo drug interaction appears low for most people. None of the listed interactions are rated major, and even the moderate ones come from lab research rather than documented effects in people.
The combination that deserves the most care involves immunosuppressants, the medicines used after an organ transplant or for autoimmune disease. Because Umckaloabo may stimulate the immune system, it could in theory work against these drugs, and even a small loss of effect matters when transplant protection is at stake. For people on blood thinners such as warfarin, the concern is much weaker: Umckaloabo contains a coumarin compound, but animal studies found no effect on clotting or on warfarin, and no bleeding problems have been reported in humans.
Although Umckaloabo appears alongside a long list of medications, that does not mean each pairing is harmful. Most entries reflect theoretical concerns based on how the herb might act in the body, not effects actually seen in people. In fact, the best-studied prediction, a bleeding risk, did not hold up when tested.
Based on HelloPharmacist’s Umckaloabo interaction data and reviewed under our editorial standards.
Drugs that interact with Umckaloabo
241 medications have a known interaction with Umckaloabo, graded by severity. Select any drug for the full evidence-based detail.
Don’t want to scroll the list? Just ask.
Tell us the medications you take and we’ll check each one against Umckaloabo using our pharmacist-reviewed interaction data.
AI summaries are generated from our Umckaloabo interaction data for education only — always confirm with your pharmacist. How we use AI
No drugs match “”.
What Severity, Likelihood & Evidence Mean
Severity — How Serious It Can Be
- Major. Clinically significant; generally best avoided, or used only under direct professional supervision.
- Moderate. May need monitoring, a dose adjustment, or separating the times you take each one.
- Minor. Generally not clinically significant, but still worth noting and mentioning to your pharmacist.
- No known interaction. Checked against our sources with nothing documented — not the same as proven safety.
Likelihood — How Well It’s Documented
- Likely. Well-controlled human studies have demonstrated the likely existence of this interaction
- Probable. Interaction has not been documented in well-controlled studies, however, the interaction has been demonstrated in some small human studies or in controlled animal studies in conjunction with multiple case reports.
- Possible. Interaction has been documented in animal or in lab research, or the interaction has been documented in humans but is limited to case reports or conflicting clinical research exists
- Unlikely. Interaction has been demonstrated in animal or in lab research but has been shown not to occur in humans.
Where This Data Comes From
- Interaction records are evidence-graded and sourced from the Natural Medicines database (TRC Healthcare), the same reference used by pharmacists and hospitals.
- Each drug listed above links to the full report for that exact Umckaloabo combination — clinical detail, likelihood, evidence level, and citations.
- Content is reviewed by licensed HelloPharmacist pharmacists — see our data sources and editorial standards.
The kinds of drugs Umckaloabo affects
Every type of medication (drug category) Umckaloabo is known to interact with. Open any category for the detail — or search your exact drug in the checker above.
Immunosuppressants
Theoretically, Pelargonium sidoides might decrease the effectiveness of immunosuppressant therapy.
In vitro research suggests that Pelargonium sidoides has immunostimulant effects.
Anticoagulant/Antiplatelet Drugs
Theoretically, Pelargonium sidoides might increase the risk of bleeding when taken with anticoagulant and antiplatelet drugs.
Pelargonium sidoides contains coumarin, which may reduce platelet aggregation. However, in animal models, Pelargonium sidoides extract does not appear to inhibit coagulation or interact with warfarin. This interaction has not been documented in humans.
Umckaloabo: Uses, Safety & Side Effects
Umckaloabo is a root extract from a South African geranium that is most studied for short-term relief of acute bronchitis and other respiratory infections. Some clinical research suggests it may help symptoms resolve a bit faster, but the quality of evidence is mixed and it is not a cure. Talk to your pharmacist or doctor before using it, especially if you are pregnant, breastfeeding, or have a chronic illness.

- Scientific name
- Pelargonium sidoides
- Family
- Geraniaceae
- Part used
- Roots
- Common forms
- Liquid extract (drops), syrup, tablets, lozenges
- Acute bronchitis
- Common cold
- Sinusitis
- Sore throat
- Upper respiratory infections
Popular and traditional uses — not proof it works. See “Uses & effectiveness” below for the evidence.
Generally well tolerated for short-term use, but quality and standardization vary by product.
Insufficient reliable information available; avoid using.
Read the full pregnancy detailInsufficient reliable information available; avoid using.
Read the full breastfeeding detailPregnancy & breastfeeding ratings are from Natural Medicines (Therapeutic Research Center). Safety guidance is general; always confirm with your pharmacist or doctor for your situation.
Overview
Umckaloabo is an herbal remedy made from the roots of Pelargonium sidoides, a flowering plant in the geranium family that grows in South Africa. It is sometimes called African geranium. The name "umckaloabo" comes from traditional African words linked to its long history of use for chest and breathing problems.
Today it is sold as a liquid extract (drops), syrup, tablets, and lozenges. People most often take it for short-term respiratory infections like the common cold, sore throat, sinus infections, and acute bronchitis. A specific standardized extract known as EPs 7630 is the form used in much of the published research.
How it works
The root contains plant compounds such as coumarins and polyphenols. Laboratory and animal studies suggest these compounds may work in a few ways: they may make it harder for bacteria to stick to cells in the airway, they may help the body's immune cells respond to viruses, and they may help loosen mucus so it is easier to clear.
Some research also suggests it has mild antiviral and anti-inflammatory effects. It is important to know that much of this evidence comes from test-tube and animal studies, so it does not fully prove how the extract works in people.
Does Umckaloabo work?
How to read these evidence grades
Natural Medicines’ 7-point scale. We show each rating’s label word-for-word.
Possibly Effective Acute Bronchitis
Oral Pelargonium sidoides may be beneficial in adults and children with acute bronchitis when initiated within 48 hours of symptom onset.
Possibly Effective Chronic obstructive pulmonary disease (COPD)
Oral Pelargonium sidoides extract (EPs 7630, Dr. Willmar Schwabe Pharmaceuticals) may decrease the frequency of exacerbations, improve symptoms, and reduce the need for antibiotics in patients with COPD; however, it does not seem to reduce the overall risk of exacerbations.
Also studied for 6 conditions — evidence insufficient to rate
Insufficient Reliable Evidence To Rate Asthma
It is unclear if oral Pelargonium sidoides extract is beneficial in children with asthma who have an active viral upper respiratory tract infection.
Insufficient Reliable Evidence To Rate Genital herpes
Although there has been interest in using oral Pelargonium sidoides for genital herpes, there is insufficient reliable information about the clinical effects of Pelargonium sidoides for this purpose.
Insufficient Reliable Evidence To Rate Herpes labialis (cold sores)
Although there has been interest in using oral Pelargonium sidoides for herpes labialis, there is insufficient reliable information about the clinical effects of Pelargonium sidoides for this purpose.
Insufficient Reliable Evidence To Rate Rhinosinusitis
Small clinical studies suggest that oral Pelargonium sidoides root extract may improve symptoms in adults with rhinosinusitis.
Insufficient Reliable Evidence To Rate Tonsillopharyngitis
It is unclear if oral Pelargonium sidoides extract is beneficial in children with tonsillopharyngitis.
Insufficient Reliable Evidence To Rate Upper respiratory tract infection (URTI)
A small clinical study suggests that oral Pelargonium sidoides root extract may improve symptoms in children with URTIs.
Source & disclaimer. Effectiveness ratings and evidence summaries are provided by Natural Medicines (Therapeutic Research Center) and shown as licensed. Where Natural Medicines hasn’t rated a use, HelloPharmacist’s pharmacists may add their own reviewed rating and evidence (each such entry is labeled). This is educational information, not medical advice — talk with your pharmacist or doctor before starting, stopping, or changing a supplement.
Safety & precautions
For short-term use, Umckaloabo is generally considered well tolerated by most adults. However, product quality and the amount of active extract can vary, so it is best to choose products from reputable manufacturers and follow the label.
There have been rare reports of liver problems in people taking Pelargonium products. If you have liver disease, a bleeding disorder, or a serious chronic illness, talk to your doctor or pharmacist before using it. Stop using it and seek care if you notice yellowing of the skin or eyes, dark urine, or severe stomach pain.
Pregnancy and breastfeeding: There is not enough reliable safety information, so it is best to avoid Umckaloabo during pregnancy and while breastfeeding. For children, only use products specifically labeled for their age group and check with a pediatrician or pharmacist first.
Side effects
Most side effects are mild and may include stomach upset, nausea, diarrhea, or heartburn. Some products, especially liquid drops, contain alcohol, which may bother some people.
Less commonly, people may have allergic reactions such as rash, itching, or swelling. Rare but more serious reactions have been reported, including possible liver injury and nosebleeds or other minor bleeding. Stop use and contact a healthcare provider if you have signs of an allergic reaction or liver trouble.
Umckaloabo: Reported Adverse Effects
Documented safety reports on Umckaloabo from the evidence-graded Natural Medicines (TRC Healthcare) database, shown word-for-word from the licensed record.
Orally, Pelargonium sidoides is generally well tolerated.
Most Common Adverse Effects:
Orally: Allergic skin rash, diarrhea, gastrointestinal upset.
Cirrhosis Hepatic
Orally, Pelargonium sidoides does not appear to cause hepatotoxicity. Evaluations of hepatotoxicity cases in patients taking Pelargonium sidoides show it was only possibly associated in 4 of the 28 reported cases. In the remaining 24 cases, Pelargonium sidoides was unlikely to be the cause of hepatotoxicity, or was excluded as the cause. Other causes of hepatotoxicity in these cases included infectious disease, pre-existing liver disease, acute pancreatitis, and hepatotoxicity due to conventional medication use.
- Teschke R, Frenzel C, Schulze J, Eickhoff A. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? Regul Toxicol Pharmacol 2012;63(1):1-9.
- Teschke R, Frenzel C, Wolff A, et al. Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement. Ann Hepatol 2012;11(4):500-12.
Diarrhea Gastrointestinal
Orally, Pelargonium sidoides has been associated with gastrointestinal upset and diarrhea.
- Bereznoy VV, Riley DS, Wassmer G, Heger M. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial. Altern Ther Health Med 2003;9
- Matthys, H., Eisebitt, R., Seith, B., and Heger, M. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine 2003;10 Suppl 4:7-17.
- Riley DS, Lizogub VG, Zimmermann A, Funk P, Lehmacher W. Efficacy and tolerability of high-dose Pelargonium extract in patients with the common cold. Altern Ther Health Med 2018;24(2):16-26.
- Matthys H, Pliskevich DA, Bondarchuk OM, Malek FA, Tribanek M, Kieser M. Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD. Respir Med 2013;107(5):691-701.
- Willcox M, Simpson C, Wilding S, et al. Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial. BMC Complement Med Ther 2021;21
- Kamin W, Behre U, Helm K, Reling B, Funk P, Malek FA. Safety of Pelargonium extract EPs 7630 in young children with acute bronchitis. Front Pediatr 2023;11:1107984.
Urticaria Immunologic
Orally, Pelargonium sidoides has been associated with over 34 reports of allergic reactions. Urticaria is the most common reaction but there were also cases of conjunctivitis, rhinitis, and systemic allergic reactions including bronchospasm, dyspnea, tachycardia, and circulatory failure.
- de Boer, H. J., Hagemann, U., Bate, J., and Meyboom, R. H. Allergic reactions to medicines derived from Pelargonium species. Drug Saf 2007;30(8):677-680.
- Matthys H, Kamin W, Funk P, Heger M. Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children. Phytomedicine 2007;14 Suppl 6:69-73.
Adverse-effects data: Natural Medicines, Therapeutic Research Center
Dosing
There is no single official dose of Umckaloabo for everyone, and the right amount depends on the specific product and its strength. Most research has used standardized extracts taken a few times a day for a short period, usually during an active respiratory infection.
Because formulations differ, the safest approach is to follow the directions on the product label and not exceed the recommended amount. Doses for children differ from those for adults. Check with your pharmacist or doctor to confirm the right product and dose, especially for a child.
Umckaloabo & Pregnancy
Umckaloabo & Breastfeeding
© 2026 Therapeutic Research Center
Pregnancy & lactation ratings: Natural Medicines, Therapeutic Research Center
References & further reading
The 16 references that drive our Umckaloabo monograph and interaction data, from the evidence-graded Natural Medicines (TRC Healthcare) database. Citations with a link open the study on PubMed or the publisher’s site.
- Chuchalin AG, Berman B, Lehmacher W. Treatment of acute bronchitis in adults with a pelargonium sidoides preparation (EPs 7630): A randomized, double-blind, placebo-controlled trial. Explore 2005;1:437-45. PubMed
- Kolodziej H, Kayser O, Radtke OA, et al. Pharmacological profile of extracts of Pelargonium sidoides and their constituents. Phytomedicine 2003;10 Suppl 4:18-24. PubMed
- Bereznoy VV, Riley DS, Wassmer G, Heger M. Efficacy of extract of Pelargonium sidoides in children with acute non-group A beta-hemolytic streptococcus tonsillopharyngitis: a randomized, double-blind, placebo-controlled trial. Altern Ther Health Med 2003;9
- Kolodziej H, Kiderlen AF. In vitro evaluation of antibacterial and immunomodulatory activities of Pelargonium reniforme, Pelargonium sidoides and the related herbal drug preparation EPs 7630. Phytomedicine 2007;14 Suppl 6:18-26. PubMed
- Koch E, Biber A. Treatment of rats with the Pelargonium sidoides extract EPs 7630 has no effect on blood coagulation parameters or on the pharmacokinetics of warfarin. Phytomedicine 2007;14 Suppl 6:40-5. PubMed
- Conrad A, Hansmann C, Engels I, et al. Extract of Pelargonium sidoides (EPs 7630) improves phagocytosis, oxidative burst, and intracellular killing of human peripheral blood phagocytes in vitro. Phytomedicine 2007;14 Suppl 6:46-51. PubMed
- Matthys H, Kamin W, Funk P, Heger M. Pelargonium sidoides preparation (EPs 7630) in the treatment of acute bronchitis in adults and children. Phytomedicine 2007;14 Suppl 6:69-73. PubMed
- Conrad A, Jung I, Tioua D, et al. Extract of Pelargonium sidoides (EPs 7630) inhibits the interactions of group A-streptococci and host epithelia in vitro. Phytomedicine 2007;14 Suppl 6:52-9. PubMed
- Matthys, H., Eisebitt, R., Seith, B., and Heger, M. Efficacy and safety of an extract of Pelargonium sidoides (EPs 7630) in adults with acute bronchitis. A randomised, double-blind, placebo-controlled trial. Phytomedicine 2003;10 Suppl 4:7-17. PubMed
- de Boer, H. J., Hagemann, U., Bate, J., and Meyboom, R. H. Allergic reactions to medicines derived from Pelargonium species. Drug Saf 2007;30(8):677-680. PubMed
- Teschke R, Frenzel C, Schulze J, Eickhoff A. Spontaneous reports of primarily suspected herbal hepatotoxicity by Pelargonium sidoides: was causality adequately ascertained? Regul Toxicol Pharmacol 2012;63(1):1-9. PubMed
- Teschke R, Frenzel C, Wolff A, et al. Initially purported hepatotoxicity by Pelargonium sidoides: the dilemma of pharmacovigilance and proposals for improvement. Ann Hepatol 2012;11(4):500-12. DOI
- Riley DS, Lizogub VG, Zimmermann A, Funk P, Lehmacher W. Efficacy and tolerability of high-dose Pelargonium extract in patients with the common cold. Altern Ther Health Med 2018;24(2):16-26.
- Matthys H, Pliskevich DA, Bondarchuk OM, Malek FA, Tribanek M, Kieser M. Randomised, double-blind, placebo-controlled trial of EPs 7630 in adults with COPD. Respir Med 2013;107(5):691-701. PubMed
- Willcox M, Simpson C, Wilding S, et al. Pelargonium sidoides root extract for the treatment of acute cough due to lower respiratory tract infection in adults: a feasibility double-blind, placebo-controlled randomised trial. BMC Complement Med Ther 2021;21 PubMed
- Kamin W, Behre U, Helm K, Reling B, Funk P, Malek FA. Safety of Pelargonium extract EPs 7630 in young children with acute bronchitis. Front Pediatr 2023;11:1107984. PubMed
This information is for education only and is not a substitute for professional medical advice. Always check with your pharmacist or doctor before starting, stopping, or combining supplements and medications.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Brands that make products with Umckaloabo
23 brands in our database make a supplement containing Umckaloabo.
Supplement products with Umckaloabo
77 products in our database contain Umckaloabo. Open any to see its full ingredient list and every drug interaction we check.
Umckaloabo: Common Questions
What is Umckaloabo used for, and does it work?
Does Umckaloabo interact with prescription medications?
How are Umckaloabo interactions rated?
Is it safe to take Umckaloabo with my medications?
Where does this Umckaloabo interaction information come from?
What is Umckaloabo used for?
Does Umckaloabo really work?
Is Umckaloabo safe to take?
Can I take Umckaloabo if I'm pregnant or breastfeeding?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Products that contain Umckaloabo
A rotating sample of real supplements in our database that list Umckaloabo — open any to see its full ingredients and every drug interaction we check.
- Natural Immune Support Blend Alcohol Free by Hawaii Pharm
- Umckaloabo Cherry Flavor by Village Vitality
- Elderberry Plus by Thymely Solutions
- Triple Immune Support by Terry Naturally
- Umckaloabo Natural Cherry Flavor by L.A. Naturals
- Chelated Zinc by Thymely Solutions
- Immune Hero by Ee Essential elements
- Ultra-Liposomal C-Buster by Aurora NutraScience
- Umckaloabo by Hawaii Pharm
- Elderberry Plus by Village Vitality
Have a question about Umckaloabo?
Our pharmacists answer your medication & supplement questions — free.